Page 28 - Indian Stock Markets

IRCTC share steams ahead 5% as Macquarie initiates with 'Outperform'

The northward movement in IRCTC share price came after foreign brokerage firm Macquarie initiated coverage with 'Outperform' rating, with a target price of Rs 900

Why did IREDA shares fail to hold gains after Q3 results? Details here

The company's net profit climbed about 27 per cent year-on-year to Rs 425.4 crore in the December quarter of financial year 2025 (Q3FY25), from Rs 335.5 crore in the same quarter a year ago (Q3FY24)

Here's why foreign brokerages see up to 36% upside in RIL; Q3 nos on Jan 16

Goldman Sachs, Bernstein, CLSA and Jefferies have retained their positive rating on RIL and believe the selling in the stock is overdone at present levels.

Stock Market Close Highlights: Sensex sheds 528pts, Nifty at 23,526; IT, financials shares dip

Stock Market Today LIVE Updates, Jan 9: In the broader markets, the Nifty MidCap and SmallCap indices were flat

Ajmera Realty rises 4% on Q3 biz nos., pares gains later on profit booking

The uptick in Ajmera Realty share price came after the company reported its operational numbers for the December quarter of financial year 2025 (Q3FY25)

Swiggy races 6% as Bernstein initiates with 'Outperform'; sees 29% upside

The northward move in the Swiggy share price came after reports suggested that global brokerage Bernstein initiated coverage with 'Outperform' rating on the Swiggy stock, with a target price of Rs 635

HSBC downgrades Indian markets to 'Neutral,' slashes Sensex target for 2025

HSBC has revised its Sensex target for the end of 2025, lowering it to 85,990, from 90,520 earlier

Manappuram Fin up 6% as RBI lifts restrictions on arm Asirvad Micro Finance

Reserve Bank of India (RBI) lifted restrictions on all four non-banking financial companies (NBFC) imposed in October for charging exorbitant interest rates to the borrowers

RIL, Bajaj Fin: Ruchit Jain of Motilal Oswal bets on 3 stocks to buy today

Stocks to Buy Today: Ruchit Jain of Motilal Oswal picks Reliance Industries, Bajaj Finance, and Bharat Dynamics as top stocks to buy in stock markets today

Chambal Fertilizers, ONGC: Religare Broking's Ajit Mishra's 2 stocks to buy

Nifty today: Ajit Mishra of Religare Broking recommends maintaining a "sell on rise" strategy for the Nifty index while prioritising prudent stock selection

Thumbs up for RIL: Jefferies, Bernstein's bullish bet lifts stock over 2%

According to reports, the New York-based brokerage Jefferies has retained a 'Buy' rating on RIL, setting a target price of Rs 1,690. The target reflects an upside of 36.19 per cent

Stock Market Close Highlights: Sensex recoups 650 pts from low, ends flat; RIL, ITC, TCS rally 2%

Stock Market Highlights, January 8, 2025: The benchmark equity indices showed great resistance on Wednesday as the BSE Sensex reovered around 650 points from its day's low to settle at 78,141.06, down

Sensex cracks 2,500 pts in 4 days, Nifty below 50-wk average; what next?

A weekly close below the 50-WMA, shall open the doors for a likely slide towards 22,275 on the Nifty. Sensex likely to test 75,200 in the near-term.

Ola Electric share tanks 5% on Sebi's administrative warning; details here

The fall in Ola Electric share price came after the markets regulator Securities and Exchange Board of India (Sebi) issued an administrative warning letter over disclosure violations

Nifty IT in bearish trend; Nifty Auto index rangebound; how to trade today?

Stock Market Today: The Nifty IT Index today is exhibiting a bearish trend in the near-term with charts signaling further downside potential

Nifty outlook indecisive, says Vinay Rajani; picks 2 stocks to buy today

Stocks to Buy Today: Narayana Hrudalaya and Pfizer shares have been rising with heavy volumes

Stock Market Closing Highlights: Sensex adds 234 points, Nifty at 23,708; Smallcap shares outperform

Markets Today Highlights: Among the broader markets, small-cap shares outperformed others, with the Nifty Smallcap100 ending up 1.35 per cent

Zydus Lifesciences rises 5% on signing agreement with CVS Caremark; Details

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025

HMPV scare: Vijaya, Dr Lal Path, healthcare stocks in focus; Time to buy?

Apollo Hospitals, Vijaya Diagnostic and Narayana Hrudayalaya have given a fresh breakout on the daily scale. Charts show that these 5 healthcare related shares can rally up to 11 per cent.

'Real stock market money is with Gujjus.. Let that sink in': Nithin Kamath

Nithin Kamath: Ahmedabad and Mumbai account for 80 per cent of equity delivery trades, Nithin Kamath said on X